Skip to main content
NVDA-1.27%AAPL+2.35%GOOGL-0.09%MSFT+0.49%AMZN+0.61%TSM-1.16%SPCX-4.45%AVGO-5.54%META+0.53%TSLA+0.41%LLY+4.76%SKHY+0.67%BRK-B+0.68%MU-2.26%JPM-0.72%WMT+1.31%AMD-4.27%ASMLa-2.18%XOM+1.45%V+1.43%JNJ+1.66%0700.HK+1.08%MA+1.22%INTC-5.14%ABBV+2.41%BAC-0.49%1398.HK+1.51%CSCO-0.79%COST+1.63%ORCL-3.46%LRCX-5.52%CVX+0.82%AMAT-4.50%AP2d-3.57%GE-3.09%CAT-3.85%KO+1.51%UNH-0.16%HSBA.L-0.20%0005.HK-0.56%MS-1.11%PG+1.75%HD+3.44%NFLX+3.34%0857.HK+1.63%DELL-8.12%BABA-0.16%GS-2.29%9988.HK-1.97%RTX-0.55%USDCHF-1.49%CADCHF-1.04%USDSEK-0.99%USDPLN-0.98%AUDCHF-0.94%GBPCHF-0.90%CHFSGD+0.89%NZDCHF-0.88%CHFJPY+0.88%USDZAR-0.86%USDTHB-0.82%EURUSD+0.81%USDNOK-0.78%USDDKK-0.77%EURHKD+0.72%EURCHF-0.70%GBPUSD+0.65%CHFNOK+0.64%USDJPY-0.64%NZDUSD+0.61%USDMXN-0.58%AUDUSD+0.55%USDSGD-0.54%EURCNH+0.53%USDCAD-0.46%CHFSEK+0.44%GBPTRY+0.41%NZDSGD+0.39%NZDMXN+0.34%GBPHKD+0.32%EURCAD+0.32%SGDJPY-0.31%GBPMXN-0.28%EURAUD+0.27%AUDNOK-0.25%AUDDKK-0.23%EURSEK-0.23%EURSGD+0.22%EURPLN-0.22%GBPZAR-0.21%USDCNH-0.20%GBPCAD+0.19%CADJPY-0.18%EURGBP+0.17%NZDCAD+0.17%EURNZD+0.16%USDILS+0.16%EURCZK-0.15%EURJPY+0.14%PLNJPY+0.14%USDTRY+0.12%GBPAUD+0.12%AUDJPY-0.11%GBPSGD+0.11%EURZAR-0.10%USDHKD-0.09%AUDNZD-0.08%AUDCAD+0.07%NOKJPY-0.06%USDCOP-0.04%EURNOK-0.02%GBPNZD+0.01%AUDSGD-0.01%GBPJPY+0.01%EURDKK0.00%NZDJPY0.00%XPTUSD+3.57%XAUUSD+3.25%GAUUSD+3.25%XAGUSD+3.12%GAGUSD+3.10%W1+2.42%COTTON+2.34%COFFEE-2.01%COCOA+1.58%C1+0.86%S1+0.65%SUGAR-0.51%BTCUSDT-13.88%BTCUSD+1.64%ETHUSD+1.02%USDTUSD+0.02%BNBUSDT-3.79%XRPUSD+1.43%SOLUSD+2.05%TRXUSDT-0.16%DOGEUSD+0.67%ADAUSDT-29.75%ZECUSDT+2.14%XMRUSDT+0.15%LINKUSD+0.05%XLMUSDT-9.01%XLMUSD+0.57%BCHUSDT+0.69%AVAXUSDT-32.43%SUIUSDT-30.54%LTCUSD+1.24%TONUSDT+27.64%TONUSD+30.10%HBARUSDT+0.55%SUIUSD+0.30%UNIUSD+2.23%UNIUSDT+4.57%TAOUSDT+0.28%NEARUSDT+19.14%AAVEUSD+1.85%ETCUSDT-27.41%DOTUSDT+0.78%ICPUSDT-1.13%PEPEUSD+9929986.05%ONDOUSDT+1.65%WLDUSDT+0.50%ATOMUSDT-0.55%JUPUSDT+0.54%ARBUSDT+1.64%INJUSDT+0.39%PENGUUSDT+100247.39%FETUSDT+0.64%TIAUSDT+2.04%SEIUSDT-0.36%PYTHUSDT-0.27%STXUSDT+1.26%IMXUSDT-1.24%OPUSDT+0.77%POLUSDT-0.76%FARTCOINUSDT+4.06%NVDA-1.27%AAPL+2.35%GOOGL-0.09%MSFT+0.49%AMZN+0.61%TSM-1.16%SPCX-4.45%AVGO-5.54%META+0.53%TSLA+0.41%LLY+4.76%SKHY+0.67%BRK-B+0.68%MU-2.26%JPM-0.72%WMT+1.31%AMD-4.27%ASMLa-2.18%XOM+1.45%V+1.43%JNJ+1.66%0700.HK+1.08%MA+1.22%INTC-5.14%ABBV+2.41%BAC-0.49%1398.HK+1.51%CSCO-0.79%COST+1.63%ORCL-3.46%LRCX-5.52%CVX+0.82%AMAT-4.50%AP2d-3.57%GE-3.09%CAT-3.85%KO+1.51%UNH-0.16%HSBA.L-0.20%0005.HK-0.56%MS-1.11%PG+1.75%HD+3.44%NFLX+3.34%0857.HK+1.63%DELL-8.12%BABA-0.16%GS-2.29%9988.HK-1.97%RTX-0.55%USDCHF-1.49%CADCHF-1.04%USDSEK-0.99%USDPLN-0.98%AUDCHF-0.94%GBPCHF-0.90%CHFSGD+0.89%NZDCHF-0.88%CHFJPY+0.88%USDZAR-0.86%USDTHB-0.82%EURUSD+0.81%USDNOK-0.78%USDDKK-0.77%EURHKD+0.72%EURCHF-0.70%GBPUSD+0.65%CHFNOK+0.64%USDJPY-0.64%NZDUSD+0.61%USDMXN-0.58%AUDUSD+0.55%USDSGD-0.54%EURCNH+0.53%USDCAD-0.46%CHFSEK+0.44%GBPTRY+0.41%NZDSGD+0.39%NZDMXN+0.34%GBPHKD+0.32%EURCAD+0.32%SGDJPY-0.31%GBPMXN-0.28%EURAUD+0.27%AUDNOK-0.25%AUDDKK-0.23%EURSEK-0.23%EURSGD+0.22%EURPLN-0.22%GBPZAR-0.21%USDCNH-0.20%GBPCAD+0.19%CADJPY-0.18%EURGBP+0.17%NZDCAD+0.17%EURNZD+0.16%USDILS+0.16%EURCZK-0.15%EURJPY+0.14%PLNJPY+0.14%USDTRY+0.12%GBPAUD+0.12%AUDJPY-0.11%GBPSGD+0.11%EURZAR-0.10%USDHKD-0.09%AUDNZD-0.08%AUDCAD+0.07%NOKJPY-0.06%USDCOP-0.04%EURNOK-0.02%GBPNZD+0.01%AUDSGD-0.01%GBPJPY+0.01%EURDKK0.00%NZDJPY0.00%XPTUSD+3.57%XAUUSD+3.25%GAUUSD+3.25%XAGUSD+3.12%GAGUSD+3.10%W1+2.42%COTTON+2.34%COFFEE-2.01%COCOA+1.58%C1+0.86%S1+0.65%SUGAR-0.51%BTCUSDT-13.88%BTCUSD+1.64%ETHUSD+1.02%USDTUSD+0.02%BNBUSDT-3.79%XRPUSD+1.43%SOLUSD+2.05%TRXUSDT-0.16%DOGEUSD+0.67%ADAUSDT-29.75%ZECUSDT+2.14%XMRUSDT+0.15%LINKUSD+0.05%XLMUSDT-9.01%XLMUSD+0.57%BCHUSDT+0.69%AVAXUSDT-32.43%SUIUSDT-30.54%LTCUSD+1.24%TONUSDT+27.64%TONUSD+30.10%HBARUSDT+0.55%SUIUSD+0.30%UNIUSD+2.23%UNIUSDT+4.57%TAOUSDT+0.28%NEARUSDT+19.14%AAVEUSD+1.85%ETCUSDT-27.41%DOTUSDT+0.78%ICPUSDT-1.13%PEPEUSD+9929986.05%ONDOUSDT+1.65%WLDUSDT+0.50%ATOMUSDT-0.55%JUPUSDT+0.54%ARBUSDT+1.64%INJUSDT+0.39%PENGUUSDT+100247.39%FETUSDT+0.64%TIAUSDT+2.04%SEIUSDT-0.36%PYTHUSDT-0.27%STXUSDT+1.26%IMXUSDT-1.24%OPUSDT+0.77%POLUSDT-0.76%FARTCOINUSDT+4.06%

Regeneron Pharmaceuticals (REGN)

NASDAQ • Healthcare

$841.55
+$31.31 (+3.9%)
Market open

August 19, 2026 at 14:18 UTC

Interactive Chart

RP

14:18:11 UTC

About Regeneron Pharmaceuticals

Name
Regeneron Pharmaceuticals
CEO
Leonard S. Schleifer
Website
www.regeneron.com
Industry
Healthcare
Year Founded
1988
Employees
15,410

Regeneron Pharmaceuticals, Inc. develops and markets biologic medicines as a biotechnology company listed on NASDAQ under REGN. Its portfolio spans eye disease, immunology, oncology, cardiovascular and infectious-disease therapies, and it generated $14.3 billion of revenue in FY2025 through a portfolio of marketed drugs and clinical-stage product candidates.

Analyst Ratings

Consensus Recommendation
Analyst consensus: 6 Buy, 0 Hold, 2 Sell
Buy6
Hold0
Sell2

Fundamentals & Financials

Revenue (TTM)
$15.5B
Net Income (TTM)
$4.3B
EPS (TTM)
$41.88
ROA (TTM)
10.37%
Current Ratio
3.34
Dividend Yield
0.15%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement

ItemQ2 FY2026
Revenue$4,290.7M
Cost of Sales$576,500K
Gross Profit$3,714.2M
Operating Income$1,420.5M
Net Income$1,296.9M
EPS$12.59

Technical Indicators

Regeneron Pharmaceuticals's Technical Indicators Summary

REGN displays a strong buy profile driven by robust trend strength and broad-based upside momentum. Price is well above short- and medium-term moving averages as well as the 200-day, and ADX in the upper 40s signals a powerful directional trend. Momentum measures and MACD are supportive of the advance, even as overbought oscillators flag stretched conditions; volume-based OBV is strongly positive, confirming participation behind the move, while volatility is moderate. Technical takeaway: overall strong buy stance.

Buy
6 signals
Neutral
0 signals
Sell
2 signals
Overall: Bullish75% Bullish signals
IndicatorValue
RSI (14)
78.54
Stochastic %K (14, 3, 3)
91.57
CCI (20)
87.88
WPR (14)
-8.55
Momentum (10)
49.58
MFI
84.05
MACD Level (12, 26)
37.96
Bollinger Bands
$633.31 - $865.83
ATR (14)
$19.61 (2.42%)
ADX (14)
47.21
OBV
6,791,518
Classic Pivot Point
$804.95
Fibonacci Pivot Point
$804.95
Exponential Moving Averages
$693.28 - $790.31(5 indicators)
Simple Moving Averages
$682.82 - $795.37(5 indicators)
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.

Today's Snapshot

It was a quietly positive last session for REGN, which ended 0.53% higher at 810.24. REGN attracts fresh institutional interest as Oxbow Advisors and M. Kulyk disclose new stakes.

Trading Volume

Below 10d avg (733.8K)

578.3K

vs S&P 500 Today

Outperforming Market

+1.34%

52-Week Position

Near highs

96.1%

Updated: August 19, 2026 at 12:53 UTC

Quote Summary

Previous CloseDay Range$810.24$805.93 - $821.02
52 Week RangeAvg. Volume$541 - $821.11820.4K
Market CapP/E Ratio$83.4B19.3

REGN Headlines

Parabilis prices upsized U.S. IPO

June 10, 2026

3 min read
View All Headlines

Peers & Related Assets

ELVELEVANCE HEALTH INC
$398.27+2.1%
CICIGNA
$278.5+1.1%
CORCENCORA INC
$316.13+1.2%
IDXXIDEXX Laboratories Inc
$572.44+3.5%
ZTSZOETIS INC CLASS A
$73.96+1.4%
ALNYALNYLAM PHARMACEUTICALS INC
$228.61+1.8%
INCYINCYTE CORP
$123.47-0.0%
UTHRUNITED THERAPEUTICS CORP
$518.27+1.9%
ARGXargenx SE
GMABGenmab A/S